Targeted drug shows promise for rare vulvar cancer
Disease control
Not yet recruiting
This phase 2 trial tests a drug called tisotumab vedotin in people with advanced squamous cell carcinoma of the vulva that has returned or spread. The drug is an antibody-drug conjugate designed to seek out and destroy cancer cells. The study aims to see how many participants' tu…
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC